Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Value of Tumor Deposits for Patients With Papillary Thyroid Carcinoma: a Retrospective Cohort Study

NCT06051838 is registered in ClinicalTrials.gov with Nanfang Hospital, Southern Medical University as lead sponsor.

NCT NCT06051838
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06051838 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Value of Tumor Deposits for Patients With Papillary Thyroid Carcinoma: a Retrospective Cohort Study
Lead sponsor
Nanfang Hospital, Southern Medical University
Phase
Observational
Overall status
Completed
Start date
November 1, 2022
Completion date
March 30, 2023
Enrollment
541 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

exploring the prognostic value of tumor deposits ptc patients